Nosher J L, Bodner L J, Ettinger L J, Siegel R L, Gribbin C, Asch J, Drachtman R A
Department of Radiology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ 08903-0019, USA.
Cardiovasc Intervent Radiol. 2001 Nov-Dec;24(6):395-9. doi: 10.1007/s00270-001-0071-1. Epub 2001 Nov 8.
To evaluate the feasibility and complications of placement of a low-profile venous access port in the chest in children requiring long-term venous access.
A low-profile peripheral arm port (PAS port; Sims Deltec, St. Paul, MN, USA) was implanted in the chest in 22 children over a 4-year period. The mean age of the study group was 6 years (range: 9 months to 20 years). Ports were placed for the administration of chemotherapy, hyperalimentation and frequent blood sampling. Sonographic guidance was used to access the internal jugular or subclavian vein in each case. A review of all inpatient and outpatient charts was undertaken to assess catheter performance and complications.
Access to the central venous circulation was successfully achieved in each case without complication. Ports remained implanted for 6579 catheter-days (mean: 299 days). Ten ports have been removed. Of three patients (13%) experiencing device-related infections (0.45 infections/1000 catheter days), two (9.1%) were unresponsive to antibiotics and removed (0.3 infections/1000 catheter days). One port was removed because of pain in the shoulder adjacent to the port implantation site. One port was removed because of difficult access. The final port was removed in order to place a dual-lumen catheter prior to bone marrow transplant. Twelve ports remain implanted. Aspiration occlusion occurred in four patients (18%). Deep venous thrombosis did not occur in any patient.
Low-profile chest ports placed by interventional radiologists in the interventional radiology suite can be placed in children as safely as traditional chest ports placed in the operating room. The incidence of infection, venous thrombosis and aspiration occlusion is comparable to that of ports placed operatively.
评估在需要长期静脉通路的儿童胸部植入低轮廓静脉通路端口的可行性及并发症。
在4年时间里,为22名儿童在胸部植入了低轮廓外周手臂端口(PAS端口;美国明尼苏达州圣保罗市西姆斯德尔泰克公司)。研究组的平均年龄为6岁(范围:9个月至20岁)。植入端口用于化疗、胃肠外营养及频繁采血。每例均采用超声引导进入颈内静脉或锁骨下静脉。对所有住院和门诊病历进行回顾,以评估导管性能及并发症。
每例均成功实现中心静脉循环通路建立,无并发症发生。端口留置时间达6579导管日(平均:299天)。已移除10个端口。在3例(13%)发生与装置相关感染的患者中(0.45例感染/1000导管日),2例(9.1%)对抗生素无反应而被移除(0.3例感染/1000导管日)。1个端口因端口植入部位邻近肩部疼痛而被移除。1个端口因通路困难而被移除。最后1个端口在骨髓移植前为放置双腔导管而被移除。仍有12个端口留置。4例患者(18%)发生抽吸堵塞。无患者发生深静脉血栓形成。
介入放射科医生在介入放射科操作室植入的低轮廓胸部端口,在儿童中植入的安全性与在手术室植入的传统胸部端口相当。感染、静脉血栓形成及抽吸堵塞的发生率与手术植入端口的发生率相当。